Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Algernon Pharmaceuticals Inc. C.AGN

Alternate Symbol(s):  AGNPF

Algernon Pharmaceuticals Inc. is a clinical-stage drug development company. The Company is focused on developing repurposed therapeutic drugs in the areas of non-alcoholic steatohepatitis (NASH), a type of liver disease, chronic kidney disease (CKD), inflammatory bowel disease (IBD), idiopathic pulmonary fibrosis (IPF) and chronic cough as well as advancing a stroke program using N, N-Dimethyltryptamine (DMT). The Company operates through two segments, which includes the development of repurposed therapeutic drugs in Canada and the facilitation of the Company’s lead drug candidates into off-label phase II clinical trials (humans) in Australia. The Company's pipeline includes NP-251 (Repirinast) and AP-188 (DMT). The Company, through its subsidiary, Algernon NeuroScience Inc., is developing AP-188 (DMT) as a potential treatment for stroke and traumatic brain injury (TBI) recovery. Its NP-251 is being developed as a potential treatment for kidney inflammation and fibrosis.


CSE:AGN - Post by User

Post by grosdavidon May 08, 2020 12:08pm
141 Views
Post# 31003589

Demand and offer

Demand and offer

When there are more buyers than sellers, in this case, sellers have the stronger hand I believe becsuse the sellers want in. If you don't sell, typically, the bids will want to increase their price. 

If you get scared by the bids size and their prices, then you shouldn't be here. That's what big boys do, place big big bids to low-ball a stock. 

My best advice, don't sell on a Friday. Monday's can usually be strong, weekends can bring any type of advancement. We could see an update for sure on Monday AM.

The waiting period shouldn't be seen as negative, something is cooking and this will be a big play in the coming weeks. I'm tired of seeing estimates in stock price, nobody knows how this can jump. We could honestly see a open at 0,55$ after a FDA approval. We could see a 0,40$ open for the PP then a close at 0,50$ that same day. That's pennystocks.

Bullboard Posts